LabCentral companies have raised more than $20 billion in funding and created more than 7,000 jobs in Massachusetts.

Marlena Fejzo’s groundbreaking work implicates the hormone GDF15 as a key player in this understudied disorder.

A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

Tiziana Life Sciences (TLSA) announced dosing has commenced at Johns Hopkins University, JHU, Autoimmunity Center of Excellence, the third ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS ...

The trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.

In a study published in Nature Neuroscience, researchers from Tiziana Life Sciences Ltd. and collaborators investigated the potential of nasal delivery of the CD3 foralumab to reduce neuroinflammation ...

EDT Tiziana Life Sciences (TLSA) files $250M mixed securities shelfLight Up your Portfolio with Spark:Easily identify stocks' risks and ...

[1],[2] About Tiziana Life Sciences Tiziana Life Sciences is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

CSP-H genes (encoding cold shock proteins) were horizontally transferred from bacteria to Triticeae and improved wheat adaptation by enhancing its tolerance to various abiotic stresses. Because ...